MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,643K
EPS
-$0.91
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
407
361
1,346*
1,769
General and administrative
1,241
1,642
1,237*
1,596
Total operating expenses
1,648
2,003
2,583
3,365
Loss from operations
-1,648
-2,003
-2,583*
-3,365
Change in fair value of warrant liability
-
-
0*
0
Interest income
5
5
5*
6
Net loss
-1,643
-1,998
-2,579*
-3,359
Deemed dividend on series b warrants
-
-
0*
-
Net loss available to common stockholders
-
-
-2,579
-
Basic EPS
-0.91
-1.61
0.569
-1.28
Diluted EPS
-0.91
-1.61
0.569
-1.28
Basic Average Shares
1,804,951
1,241,001
-4,532,151
2,621,498
Diluted Average Shares
1,804,951
1,241,001
-4,532,151
2,621,498
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,643K
(43.19%↑ Y/Y)
Interest income
$5K
(0.00%↑ Y/Y)
Loss from operations
-$1,648K
(43.11%↑ Y/Y)
Total operating
expenses
$1,648K
(-43.11%↓ Y/Y)
General and
administrative
$1,241K
(21.91%↑ Y/Y)
Research and development
$407K
(-78.34%↓ Y/Y)
Buy us a coffee
GRI Bio, Inc. (GRI)
GRI Bio, Inc. (GRI)